DXCM
Dexcom IncCompany with tickers: DXCM
CIK
1093557
CUSIP
252131107
Shares Outstanding
385,872,977
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $1,191,900,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Cost of Revenue | — | ||||
| Gross Profit | $750,300,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Operating Expenses | $495,000,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Research & Development | $145,300,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Operating Income | $255,300,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| Net Income | $199,500,000 | USD | 2026-03-31 | 10-Q | 2026-04-30 |
| EPS (Basic) | $0.52 | USD/shares | 2026-03-31 | 10-Q | 2026-04-30 |
| EPS (Diluted) | $0.51 | USD/shares | 2026-03-31 | 10-Q | 2026-04-30 |